Potential use of vaccines in the primary prevention of breast cancer in high-risk patients

Research output: Contribution to journalArticle


Cancer vaccines are an emerging therapeutic and prophylactic modality that may play a more important role in cancer prevention and treatment in the future. Therapeutic cancer vaccines are designed to generate a targeted, immune-mediated antitumor response. Successful prophylactic vaccines are those against oncogenic viral infections, such as the human papillomavirus and cervical cancer. However, a tough challenge for the majority of tumor vaccines is the self-nature of tumor antigens. Ongoing studies are investigating methods to enhance vaccine strategies including immune-modulating agents. The present review analyzes the potential use of vaccines in the primary prevention of breast cancer, focusing on the recent extension of vaccine target selection to self-proteins that are overexpressed during the early stages of tumor development but whose expression no longer occurs as we age, a feature that may avoid clinically significant autoimmune sequelae.

Original languageEnglish
Pages (from-to)281-287
Number of pages7
JournalBreast Care
Issue number4
Publication statusPublished - Aug 2012



  • Breast cancer prevention
  • Vaccines

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this